Sinovac Coronavirus Vaccine
-
{
- All
- News
-
China's Sinovac Shot Controls Covid In Brazil Town After 75% Covered
- Tuesday June 1, 2021
- World News | Bloomberg
A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing.
-
www.ndtv.com
-
Indonesia Approves China's Sinovac Covid Vaccine Amid Rise In Infections
- Monday January 11, 2021
- World News | Reuters
Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
-
www.ndtv.com
-
China Covid Vaccine Induces Quick Immune Response Within 4 Weeks: Study
- Wednesday November 18, 2020
- World News | Reuters
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
-
www.ndtv.com
-
China's Sinovac Shot Controls Covid In Brazil Town After 75% Covered
- Tuesday June 1, 2021
- World News | Bloomberg
A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing.
-
www.ndtv.com
-
Indonesia Approves China's Sinovac Covid Vaccine Amid Rise In Infections
- Monday January 11, 2021
- World News | Reuters
Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
-
www.ndtv.com
-
China Covid Vaccine Induces Quick Immune Response Within 4 Weeks: Study
- Wednesday November 18, 2020
- World News | Reuters
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
-
www.ndtv.com